Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) As Monotherapy or with Ruxolitinib in Patients with Anemia Due to Myelofibrosis

Blood (2023) 142 (Supplement 1): 624.

https://doi.org/10.1182/blood-2023-179291

Published: 2023

Journal Articles

Thrombotic and Bleeding Events in Japanese Adolescent and Young Adult PV and ET: Results from Japanese Multicenter Retrospective Study

Blood (2023) 142 (Supplement 1): 1831.

https://doi.org/10.1182/blood-2023-180561

Published: 2023

Journal Articles

Novel Protease-Mediated Double Antigen Recognizing Chimeric Antigen Receptor (CAR) Enhances Directionality of CAR-T Cell Activity and Improves Target Cell Specificity

Satoru Aoyama, Ayako Nogami, Sadakatsu Ikeda, Takehiko Mori

Blood (2022) 140 (Supplement 1): 4533–4534.

https://doi.org/10.1182/blood-2022-165658

Published: 2022

Journal Articles

TPL2, a New Prognostic Factor and a Potential Therapeutic Target in ABC-DLBCL

Kota Yoshifuji, Yotaro Motomura, Makiko Saito, Ayako Nogami, Genji Kawade, Shiori Watabe, Kouhei Yamamoto, Takehiko Mori, Toshikage Nagao

Blood (2022) 140 (Supplement 1): 5915–5916.

https://doi.org/10.1182/blood-2022-162875

Published: 2022

Journal Articles

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Hiroyuki Takamatsu, MD PhD, Shohei Mizuno, MD PhD, Tsutomu Takahashi, MD PhD, Shin-Ichi Fuchida, MD PhD, Ichiro Hanamura, MD PhD, Fumihiko Nakamura, MD PhD, Takehiko Mori, MD PhD, Yuta Katayama, MD PhD, Noriko Doki, MD PhD, Nobuhiro Tsukada, MD PhD, Tatsuo Ichinohe, Yoshinobu Kanda, MD PhD, Yoshiko Atsuta, MD PhD, Kazutaka Sunami, MD PhD

Blood (2019) 134 (Supplement_1): 4358.

https://doi.org/10.1182/blood-2019-123607

Published: 2019

Journal Articles

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Ayumi Fujimoto, MD, Nobuhiro Hiramoto, MD, Satoshi Yamasaki, MD PhD, Yoshihiro Inamoto, MD PhD, Naoyuki Uchida, MD PhD, Tetsuo Maeda, MD, Takehiko Mori, MD PhD, Yoshinobu Kanda, MD PhD, Tadakazu Kondo, MD PhD, Junji Tanaka, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2018) 132 (Supplement 1): 250.

https://doi.org/10.1182/blood-2018-99-110424

Published: 2018

Journal Articles

Efficacy and Safety of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma in the Era of Novel Agents

Shohei Mizuno, MD PhD, Koji Kawamura, MD PhD, Ichiro Hanamura, MD PhD, Kazutaka Sunami, MD PhD, Takehiko Mori, MD PhD, Fumihiko Nakamura, Shinsuke Iida, MD PhD, Hideyuki Nakazawa, PhD MD, Masanori Makita, Shinichi Kako, MD, Masashi Sawa, MD PhD, Yasunori Ueda, MD PhD, Hiroyuki Takahashi, MD PhD, Yoshinobu Kanda, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Hiroyuki Takamatsu, MD PhD, Akiyoshi Takami, MD

Blood (2018) 132 (Supplement 1): 3437.

https://doi.org/10.1182/blood-2018-99-109905

Published: 2018

Journal Articles

Mixed Chimerism and Secondary Engraftment Failure in Allogeneic Transplantation for Aplastic Anemia

Shinichi Kako, MD, Hirohito Yamazaki, MD PhD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Shuichi Ota, MD, Yoshinobu Kanda, MD PhD, Tetsuo Maeda, MD, Jun Kato, MD, Ken Ishiyama, MD PhD, Ken-Ichi Matsuoka, MD PhD, Toshihiro Miyamoto, MD PhD, Takahiro Fukuda, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Takehiko Mori, MD PhD

Blood (2018) 132 (Supplement 1): 4631.

https://doi.org/10.1182/blood-2018-99-111175

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study

Shinichi Kako, MD, Yoshinobu Kanda, MD PhD, Makoto Onizuka, MD PhD, Nobuyuki Aotsuka, Kensuke Usuki, MD PhD, Takayoshi Tachibana, MD, Takeshi Kobayashi, MD, Jun Kato, MD, Shingo Yano, MD PhD, Hiroaki Shimizu, MD PhD, Katsuhiro Shono, Masatsugu Tanaka, MD, Shokichi Tsukamoto, MD, Takehiko Mori, MD PhD, Etsuko Yamazaki, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2018) 132 (Supplement 1): 2101.

https://doi.org/10.1182/blood-2018-99-115105

Published: 2018

Journal Articles

A Prospective, Multicenter Surveillance Study for Adverse Events Associated with Hematopoietic Stem Cell Infusion: Analysis of Pediatric and Low Body-Weight Recipients

Blood (2018) 132 (Supplement 1): 2105.

https://doi.org/10.1182/blood-2018-99-118328

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients

Yoshimitsu Shimomura, MD, Masahiko Hara, Takaaki Konuma, MD PhD, Hidehiro Itonaga, MD, PhD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Naoyuki Uchida, MD PhD, Takehiko Mori, MD PhD, Junji Tanaka, MD PhD, Takahiro Fukuda, MD PhD, Yoshiko Atsuta, MD PhD, Takayuki Ishikawa, Ken Ishiyama, MD PhD

Blood (2018) 132 (Supplement 1): 3452.

https://doi.org/10.1182/blood-2018-99-113275

Published: 2018

Journal Articles

Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

Yoshimitsu Shimomura, MD, Masahiko Hara, Takayoshi Tachibana, MD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Naoyuki Uchida, MD PhD, Takehiko Mori, MD PhD, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Takayuki Ishikawa, Ken Ishiyama, MD PhD

Blood (2018) 132 (Supplement 1): 3453.

https://doi.org/10.1182/blood-2018-99-113258

Published: 2018

Journal Articles

Evaluation and Significance of CD25 Expression in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells in Chronic Myelogenous Leukemia Patients

Hidenori Kasahara, MDPhD, Daiki Karigane, MDPhD, Rie Yamazaki, MD, Shinya Fujita, MD, Kouhei Shirosita, MD, Masatoshi Sakurai, MD, Yuya Koda, MD, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD, Takehiko Mori, MD PhD, Yoko Yatabe, Tomoko Arai, Mitsuru Murata, MDPhD, Hiroshi Kobayashi, MD PhD, Keiyo Takubo, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2018) 132 (Supplement 1): 1723.

https://doi.org/10.1182/blood-2018-99-111586

Published: 2018

Journal Articles

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Michihide Tokuhira, MD, Shuntaro Saito, MD, Ayumi Okuyama, MD, Katsuya Suzuki, MD, Morihiro Higashi, MD, Shuju Momose, MD, Takayuki Shimizu, MD, Takehiko Mori, MD PhD, Tomoe Anan-Nemoto, MD, Koichi Amano, MD, Shinichiro Okamoto, MD PhD, Tsutomu Takeuchi, MD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD

Blood (2017) 130 (Supplement 1): 4024.

https://doi.org/10.1182/blood.V130.Suppl_1.4024.4024

Published: 2017

Journal Articles

Adverse Events Associated with Cryopreserved and Non-Cryopreserved Hematopoietic Stem Cell Infusion: A Prospective and Multicenter Surveillance Study

Kazuhiko Ikeda, MD PhD, Yoshiki Okuyama, MD, Minami Yamada-Fujiwara, MD PhD, Heiwa Kanamori, MD PhD, Shin-ichiro Fujiwara, MD PhD, Kazuo Muroi, MDPhD, Takehiko Mori, MD PhD, Kinuyo Kasama, MD, Tohru Iseki, MD PhD, Tokiko Nagamura-Inoue, MDPhD, Nobuharu Fujii, MD PhD, Takashi Ashida, MD PhD, Kazuaki Kameda, MD, Asao Hirose, MDPhD, Tsutomu Takahashi, MD PhD, Kazuhiro Nagai, MD, Keiji Minakawa, BS, MT, Ryuji Tanosaki, MD PhD, Hitoshi Ohto, MD PhD

Blood (2017) 130 (Supplement 1): 1968.

https://doi.org/10.1182/blood.V130.Suppl_1.1968.1968

Published: 2017

Journal Articles

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Saiko Kurosawa, MD, Kumi Oshima, Takuhiro Yamaguchi, Atsumi Yanagisawa, Takahiro Fukuda, Heiwa Kanamori, MD, Takehiko Mori, MD PhD, Satoshi Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Akio Kohno, Aika Seto, MD, Yukari Umemoto, Takanori Teshima, MD PhD, Shuichi Taniguchi, MD PhD, Takuya Yamashita, Yoshiko Atsuta, MD PhD

Blood (2016) 128 (22): 1240.

https://doi.org/10.1182/blood.V128.22.1240.1240

Published: 2016

Journal Articles

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Katsuto Takenaka, MD PhD, Kazuya Shimoda, MD, PhD, Naoyuki Uchida, MDPhD, Taizo Shimomura, MD PhD, Koji Nagafuji, MD PhD, Tadakazu Kondo, MD PhD, Hirohiko Shibayama, MDPhD, Takehiko Mori, MD PhD, Kensuke Usuki, MD PhD, Taichi Azuma, MDPhD, Yutaka Tsutsumi, MD PhD, Junji Tanaka, MD PhD, Hitomi Dairaku, Keitaro Matsuo, MDPhD, Keiya Ozawa, MD PhD, Mineo Kurokawa, MD, PhD, Shunya Arai, MD, PhD, Koichi Akashi, MD PhD

Blood (2016) 128 (22): 3126.

https://doi.org/10.1182/blood.V128.22.3126.3126

Published: 2016

Journal Articles

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Eri Matsuki, MD PhD MPH, Masatoshi Sakurai, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Taku Kikuchi, MD, Takayuki Shimizu, MD PhD, Kenji Yokoyama, MD PhD, Takehiko Mori, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1887.

https://doi.org/10.1182/blood.V128.22.1887.1887

Published: 2016

Journal Articles

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Masatoshi Sakurai, MD PhD, Takehiko Mori, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Keiichi Tozawa, MD, Eri Matsuki, MD PhD MPH, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1888.

https://doi.org/10.1182/blood.V128.22.1888.1888

Published: 2016

Journal Articles

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Daiki Karigane, MD, Hidenori Kasahara, MD, Masatoshi Sakurai, MD PhD, Eri Matsuki, MD PhD MPH, Keiichi Tozawa, MD, Yuya Koda, MD, Takaaki Toyama, MD, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Takehiko Mori, MD PhD, Yoko Yatabe, Tomoko Arai, Takayuki Mitsuhashi, MD, Mitsuru Murata, MD PhD, Hiroshi Kobayashi, MD PhD, Keiyo Takubo, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 3061.

https://doi.org/10.1182/blood.V128.22.3061.3061

Published: 2016

NARROW

Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) As Monotherapy or with Ruxolitinib in Patients with Anemia Due to Myelofibrosis

Thrombotic and Bleeding Events in Japanese Adolescent and Young Adult PV and ET: Results from Japanese Multicenter Retrospective Study

Novel Protease-Mediated Double Antigen Recognizing Chimeric Antigen Receptor (CAR) Enhances Directionality of CAR-T Cell Activity and Improves Target Cell Specificity

TPL2, a New Prognostic Factor and a Potential Therapeutic Target in ABC-DLBCL

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Efficacy and Safety of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma in the Era of Novel Agents

Mixed Chimerism and Secondary Engraftment Failure in Allogeneic Transplantation for Aplastic Anemia

Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study

A Prospective, Multicenter Surveillance Study for Adverse Events Associated with Hematopoietic Stem Cell Infusion: Analysis of Pediatric and Low Body-Weight Recipients

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients

Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

Evaluation and Significance of CD25 Expression in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells in Chronic Myelogenous Leukemia Patients

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Adverse Events Associated with Cryopreserved and Non-Cryopreserved Hematopoietic Stem Cell Infusion: A Prospective and Multicenter Surveillance Study

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only